Overview
Status
Active
Registry date
2012-10-26
Share capital
10,000.00 PLN
Registered address
Aleje Jerozolimskie 65/79, 00-697 Warszawa, Poland
Electronic delivery address
AE:PL-30175-78293-VEVAH-18
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2025, 13 days late).
- 202528/07/2026
- 202403/07/2025
- 202331/05/2024
- 202230/05/2023
- 202130/05/2022
- 202002/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 3.39mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 810.27kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 2.35mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 5.43mMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Clorinda Mercuri – Management Board Member
Marcin Piotr Har – President of the Management Board
Manner of representation
The company is represented by each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
D.m.g. Italia S.r.l. | 76 | $2,052.94 | 76% |
Marcin Piotr Harage 63 | 12 | $324.15 | 12% |
Others | 12 | $324.15 | 12% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2013-04-04.
14 1240 6218 1978 0010 4766 5278
29 1240 6218 1111 0010 4766 5193
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrala Farmaceutyczna CefarmS.A. | $457,052,669.59 | cefarm.com.pl | ||
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| IMC Impomed CentrumS.A. | $4,447,564.10 | impomed.pl | ||
| Gtm-Mobil M-T T.Walisiewiczsp. k. | $3,438,533.82 | gtmmobil.com.pl | ||
| Reynolds Medicalsp. z o.o. | $3,313,657.78 | reymed.pl | ||
| Balmed Polandsp. z o.o. | $3,140,735.80 | balmed.it | ||
| Medikon Polskasp. z o.o. | $2,666,944.24 | medikon.pl | ||
| Petronafsp. z o.o. | $2,499,010.09 | petronaf.com | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Novisc Pharmasp. z o.o. | $806,018.56 | novisc.com |
Change history
| Date | Event | |
|---|---|---|
| 2015-07-08 | PKD change (Removed: 103 codes) | |
| 2012-12-17 | Address change (Aleje Jerozolimskie 65/78, 00-697, Warszawa → Aleje Jerozolimskie 65/79, 00-697, Warszawa) | |
| 2012-10-26 | Entered in the register |
FAQ
The main business activity of DMG Polska focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on October 26, 2012.
The headquarters is located at: Aleje Jerozolimskie 65/79, 00-697 Warszawa.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company's revenue reached $3,392,563.
Yes, in 2025 the company achieved a net profit of $810,274.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $1,538,825 in 2025, representing 65% of all operating expenses.
Last updated: 2026-07-28